When it comes to modern medical weight loss in the UK, two names completely dominate online searches: Mounjaro and Wegovy.
These weekly injections have completely transformed how we treat obesity and metabolic health. However, because they both target weight loss, many people are left wondering: What is the actual difference between semaglutide and tirzepatide? And more importantly, which one should you buy?
If you are trying to cut through the social media noise to find real, clinically backed answers, this head-to-head breakdown will help you make an informed decision. You can explore your eligibility and start your regulated treatment journey today through WellAssist Weight Management.
How They Work: Single vs. Dual Hormone Action
The fundamental difference between these two treatments lies in their active ingredients and how they interact with your body’s natural chemistry.
- Wegovy (Semaglutide): This is a GLP-1 receptor agonist. It mimics a single natural hormone (GLP-1) that is released after you eat to signal to your brain that you are full, while also slowing down how quickly your stomach empties.
- Mounjaro (Tirzepatide): This is a dual GIP/GLP-1 receptor agonist. It mimics two metabolic hormones. In addition to targeting GLP-1 receptors, it also mimics GIP (gastric inhibitory polypeptide), which helps regulate blood sugar and improves how your body breaks down and stores fat.
Because of this dual-action mechanism, clinical trials show that Mounjaro typically achieves slightly higher overall weight reduction than standard doses of Wegovy.
| Feature | Mounjaro (Tirzepatide) | Wegovy (Semaglutide) |
| Hormones Mimicked | Dual: GIP & GLP-1 | Single: GLP-1 |
| Average Weight Loss | Up to 22.5% of body weight | 15% to 21% of body weight |
| How It’s Taken | Once-weekly injection (KwikPen) | Once-weekly injection (Pre-filled pen) |
| Standard Dosing | 2.5mg up to 15mg | 0.25mg up to 2.4mg (now up to 7.2mg) |
| Common Side Effects | Nausea, diarrhoea, mild indigestion | Nausea, constipation, acid reflux |
| UK Availability | Private prescription & NHS rollout | Private prescription & NHS specialist clinics |
| Check Eligibility | Consult on Mounjaro | Consult on Wegovy |
Which Medication Fits Your Profile?
Wegovy might be your best option if…
- You want established real-world data: Wegovy has been on the market longer than Mounjaro, meaning it has a broader history of long-term real-world safety data.
- You have cardiovascular risks: In 2026, NHS guidelines expanded to specifically recommend Wegovy for adults with a history of cardiovascular disease (like heart attacks or strokes) and a BMI of 27+ because of its proven heart-protective benefits.
- You want a gentler start: Some individuals find that a single-hormone agonist is easier for their digestive system to tolerate during the first few weeks of treatment.
- 👉 [Check Wegovy Price & Availability]
Mounjaro might be your best option if…
- Your primary goal is maximum weight reduction: Because of its dual-receptor design, Mounjaro has shown the highest average weight loss percentages in clinical obesity trials to date.
- You have Type 2 Diabetes or insulin resistance: Mounjaro’s dual mechanism makes it exceptionally powerful at managing blood sugar levels alongside weight loss.
- You plateaued on Wegovy: It is very common for patients who have hit a weight loss wall on semaglutide to successfully restart their progress by switching to tirzepatide under clinical supervision.
Some other product you should buy:
https://wellassist.co.uk/product/retatrutide-40mg-pen/
https://wellassist.co.uk/product/synedica-retatrutide-40mg/
https://wellassist.co.uk/product/nervisign-pregabalin-300mg-capsules/
https://wellassist.co.uk/product/5mg-diazepam/
Clinical evidence shows that obesity is a chronic metabolic condition. Withdrawal studies demonstrate that when patients completely stop taking Wegovy or Mounjaro, they often regain a portion of the lost weight. These treatments are designed to be used as long-term tools alongside permanent dietary and lifestyle modifications.
Yes, but you must do it under medical supervision. Patients switching between these medications generally require a “washout period” (usually at least 7 days) to ensure the first medication has left their system before safely starting the other. Your prescriber will also determine if you need to start back at the lowest dose of the new medication to prevent severe gastrointestinal side effects
